Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Oral IFN Alpha for Behçet's Disease Oral Ulcers
NCT00483184Phase 2Completed
- Sponsor
- Nobel İlaç
- Start
- Apr 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of interferon alfa in Behçet's disease (BD) (3 arms), sponsored by Nobel İlaç. Primary endpoints: Comparison of Patients Experiencing a Sustained Response and Change in Total Ulcer Burden at 12 weeks. Started Apr 2006; status: completed.
02
Drugs
interferon alfa
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT00483184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483184.